P2X receptors counteract the vasodilatory effects of endothelium derived hyperpolarising factor

European Journal of Pharmacology

Volumn 390, Issue 1-2, 2000, Pages 173-180

  Malmsjö, Malin ^a   Edvinsson, Lars ^a   Erlinge, David ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

EDHF (endothelin derived hyperpolarising factor); Endothelium; P2 receptor; Purine; Pyrimidine; Vasodilatation

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; ACETYLCHOLINE; ADENOSINE 5' O (2 THIODIPHOSPHATE); ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; APAMIN; CHARYBDOTOXIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; HEXOKINASE; INDOMETACIN; N(G) NITROARGININE; NITRIC OXIDE; NORADRENALIN; NUCLEOTIDE; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; RECEPTOR SUBTYPE; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; FEMALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION;

ANIMALS; BIOLOGICAL FACTORS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; MESENTERIC ARTERIES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; NITROARGININE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2; VASODILATION; VASODILATOR AGENTS;

EID: 0034712072     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00010-8     Document Type: Article

References (39)

1. Bauersachs J., Popp R., Hecker M., Sauer E., Flemming I., Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation. 94:1996;3341-3347.
2. Brandes R.P., Behra A., Lebherz C., Boger R.H., Bode-Boger S.M., Phivthong-Ngam L., Mugge A. N(G)-nitro-L-arginine-and indomethacin-resistant endothelium-dependent relaxation in the rabbit renal artery: effect of hypercholesterolemia. Atherosclerosis. 135:1997;49-55.
3. Chataigneau T., Feletou M., Thollon C., Villeneuve N., Vilaine J.-P., Duhault J., Vanhoutte P.M. Cannabinoid CB1 receptor and endothelium-dependent hyperpolarization in guinea-pig, rat mesenteric and porcine coronary arteries. Br. J. Pharmacol. 123:1998;968-974.
4. Chen G., Suzuki H., Weston A.H. Acetylcholine releases endothelial-derived hyperpolarising factor and EDRF from rat blood vessels. Br. J. Pharmacol. 95:1988;1165-1174.
5. Chen G., Yamamoto Y., Miwa K., Suzuki H. Hyperpolarization of arterial smooth muscle induced by endothelial humoral substances. Am. J. Physiol. 260:1991;H1888-H1892.
6. Corriu C., Feletou M., Canet E., Vanhoutte P.M. Endothelium-derived factors and hyperpolarization of the carotid artery of the guinea-pig. Br. J. Pharmacol. 119:1996;959-964.
7. Evans R.J., Kennedy C. Characterisation of P2-purinoceptors in the smooth muscle of the rat tail artery: a comparison between contractile and electrophysiological responses. Br. J. Pharmacol. 113:1994;853-860.
8. Fujii K., Tominaga M., Ohmori S., Kobayashi K., Koga T., Takata Y., Fujishima M. Decreased endothelial-dependent hyperpolarizations to acetylcholine in smooth muscle of the mesenteric artery of spontaneously hypertensive rats. Circ. Res. 70:1992;660-669.
9. Furchgott R.F., Vanhoutte P.M. Endothelium-derived relaxing and contracting factors. FASEB J. 3:1989;2007-2018.
10. Garland C.J., Plane F., Kemp B.K., Cocks T.M. Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol. Sci. 16:1995;23-30.
11. Goez U., Prada D., Pletscher A. Adenine-, guanine-and uridine-5′-phosphonucleotides in blood platelets and storage organelles of various species. J. Pharmacol. Exp. Ther. 178:1971;210-215.
12. Gordon J.L. Extracellular ATP: effects, sources and fate. Biochem. J. 233:1986;309-319.
13. Harden T.K., Nicholas R.A., Schlater J.B., Lazarowski E.R., Boyer J.L. Pharmacological selectivities of molecularly defined subtypes of P2Y receptors. Turner J.T., Weisman G.A., Fedan J.S. The P2 Nucleotide Receptors. 1998;109-134 Human Press, Totowa, NJ.
14. Huang A.H., Busse R., Bassenge E. Endothelium-dependent hyperpolarization of smooth muscle cells in rabbit femoral arteries is not mediated by EDRF (nitric oxide). Naunyn-Schmiedeberg's Arch. Pharmacol. 338:1988;438-442.
15. Jacobson K.A., Kim Y.-C., Camaioni E., van Rhee A.M. Structure activity relationships of P2 receptor agonists and antagonists. Turner J.T., Weisman G.A., Fedan J.S. The P2 Nucleotide Receptors. 1998;81-109 Human Press, Totowa, NJ.
16. Kasakov L., Burnstock G. The use of the slowly degradable analog, αβ-methylene ATP, to produce desensitation of the P2-purinoceptor: effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder. Eur. J. Pharmacol. 86:1983;291-294.
17. 1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megacaryoblastic cells. FEBS Lett. 403:1997;26-30.
18. Makino A., Kamata K. Elevated plasma endothelin-1 in streptozotocin-induced diabetic rats and responsiveness of the mesenteric arterial bed to endothelin-1. Br. J. Pharmacol. 123:1998;1065-1072.
19. 1-receptors in resistance arteries. Cardiovasc. Res. 43:1999a;219-227.
20. Malmsjö M., Bergdahl A., Zhao X., Sun X., Hedner T., Edvinsson L., Erlinge D. Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure. Cardiovasc. Res. 43:1999b;200-209.
21. Malmsjö M., Edvinsson L., Erlinge D. P2U-receptor mediated endothelium-dependent but nitric oxide independent vascular relaxation. Br. J. Pharmacol. 123:1998;719-729.
22. Malmsjö M., Erlinge D., Högestätt E., Zygmunt P. P2Y-receptors on the endothelium induce hyperpolarisation of vascular smooth muscle cells by release of endothelium derived hyperpolarising factor. Eur. J. Pharmacol. 364:1999;169-173.
23. McCulloch A.I., Randall M.D. Sex differences in the relative contributions of nitric oxide and EDHF to agonist-stimulated endothelium-dependent relaxation in the rat isolated mesenteric arterial bed. Br. J. Pharmacol. 123:1998;1700-1706.
24. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, patophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142.
25. Murphy M.E., Brayden J.E. Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels. J. Physiol. (Lond.). 486:1995;47-58.
26. Nicholas R.A., Watt W.C., Lazarowski E.R., Li Q., Harden T.K. Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor. Mol. Pharmacol. 50:1996;224-229.
27. Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 50:1998;413-491.
28. Saïag B., Hillaire-Buys D., Chapal P., Pape B., Allain H., Loubatières-Mariani M.M. Study of the mechanisms involved in adenosine-5′-O-(2-thiodiphosphate) induced relaxation of the thoracic aorta and pancreatic vascular bed. Br. J. Pharmacol. 118:1996;804-810.
29. Seifert R., Schultz G. Involvement of pyrimidinoceptors in the regulation of cell function by uridine and uracil nucleotides. Trends Pharmacol. Sci. 10:1989;365-369.
30. Taylor S.G., Weston A.H. Endothelium-derived hyperpolarising factor: a new endogenous inhibitor from the vascular endothelium. Trends Pharmacol. Sci. 9:1988;272-274.
31. Valera S., Hussy N., Evans R.J., Adami N., North R.A., Surprenant A., Buell G. A new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP. Nature. 371:1994;516-519.
32. Vargas F., Osuna A., Fernandez-Rivas A. Vascular reactivity and flow-pressure curve in isolated kidneys from rats with N-nitro-L-arginine methyl ester-induced hypertension. J. Hypertens. 14:1996;373-379.
33. Vulchanova L., Arvidson U., Riedl M., Wang J., Buell G., Surprenant A., North R.A., Elde R. Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry. Proc. Natl. Acad. Sci. USA. 93:1996;8063-8067.
34. Webb T.E., Henderson D.J., Roberts J.A., Barnard E.A. Molecular cloning and characterisation of the rat P2Y4 receptor. J. Neurochem. 7:1998;11348-11357.
35. White R., Heily C.R. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. Br. J. Pharmacol. 122:1997;1573-1584.
36. You J., Johnsson T.D., Childres W.F., Bryan R.M. Endothelial-mediated dilatations of rat middle cerebral arteries by ATP and ADP. Am. Physiol. 273:1997;H1472-H1477.
37. Zygmunt P.M., Grundemar L., Högstätt E.D. Endothelium-dependent relaxation resistant to Nω-nitro-L-arginine in the rat hepatic artery and aorta. Acta. Physiol. Scand. 152:1994;107-114.
38. Zygmunt P.M., Högestätt E.D. Role of potassium channels in endothelium-dependent relaxation resistant to nitroarginine in the rat hepatic artery. Br. J. Pharmacol. 117:1996;1600-1606.
39. Zygmunt P.M., Plane F., Paulsson M., Garland C.J., Högestätt E.D. Interactions between endothelium-derived relaxing factors in the rat hepatic artery: focus on regulation of EDHF. Br. J. Pharmacol. 124:1998;992-1000.